Persistence of HCV replication in sirna-treated HCV replicon cells is correlated with the development of HCV mutations

被引：0
|
作者：
Konishi, M
Kaito, M
Adachi, Y
Wu, CH
Wu, GY
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A698 / A698
页数：1
相关论文
共 50 条
  • [41] Persistence of HCV-RNA in mommuclear cells after HCV elimination from the serum during interferon therapy
    Januszkiewicz, D
    Wysocki, F
    Zawada, M
    Nowicka, K
    Pernak, M
    Rembowksa, J
    Lewandowski, K
    Nowak, J
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S100 - S100
  • [42] VX-950: A tight-binding HCV protease inhibitor with a superior sustained inhibitory response in HCV replicon cells.
    Lin, K
    Gates, CA
    Luong, YP
    Perni, RB
    Kwong, AD
    HEPATOLOGY, 2003, 38 (04) : 222A - 222A
  • [43] Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV
    Chu, CM
    Yeh, CT
    Sheen, IS
    Liaw, YF
    GUT, 2002, 51 (01) : 95 - 99
  • [44] Quasispecies analysis of HCV in liver, peripheral blood mononuclear cells and plasma: Evidence for alternative sites of HCV replication?
    Maggi, F
    Fornai, C
    Vatteroni, ML
    Giorgi, M
    Morrica, A
    Pistello, M
    Cammarota, G
    Marchi, S
    Ciccorossi, P
    Ricchiuti, A
    Bionda, A
    Bendinelli, M
    HEPATOLOGY, 1997, 26 (04) : 1705 - 1705
  • [45] Alcohol treatment increases HCV-RNA and viral protein expression in HUH7 cells expressing HCV-replicon, and this effect is modulated by 5-UTR HCV region
    Trujillo-Murillo, KD
    Garza-Rodriguez, L
    Martínez-Rodríguez, HG
    Barrera-Saldaña, HA
    Bosques-Padilla, FJ
    Ramos-Jiménez, J
    Rivas-Estilla, AM
    HEPATOLOGY, 2005, 42 (04) : 557A - 557A
  • [46] Persistence of HCV in hepatic and extrahepatic cells from asymptomatic non viremic chronic anti-HCV carriers.
    Zignego, AL
    Montalto, G
    Ruggeri, I
    Monti, M
    Giannini, C
    Careccia, G
    Fontana, R
    LaVilla, G
    Gentilini, P
    HEPATOLOGY, 1996, 24 (04) : 1006 - 1006
  • [47] HCV-siRNA and lactose modified cationic liposome complex could efficiently target to the HCV genome in hepatic parenchymal cells
    Kohara, M
    Watanabe, T
    Umehara, T
    Sudoh, M
    Yano, J
    Miyagishi, M
    Taira, K
    Inoue, K
    Yoshiba, M
    HEPATOLOGY, 2005, 42 (04) : 695A - 695A
  • [48] Replication of HCV in hepatocellular carcinoma cells detected by in situ hybridization
    Ohishi, M
    Sakisaka, S
    Kawaguchi, T
    Koga, H
    Sasatomi, K
    Harada, M
    Sata, M
    Tanikawa, K
    GASTROENTEROLOGY, 1997, 112 (04) : A1350 - A1350
  • [49] A novel class of geldanamycin derivatives as HCV replication inhibitors targeting on Hsp90: synthesis, structure–activity relationships and anti-HCV activity in GS4.3 replicon cells
    Guang-zhi Shan
    Zong-gen Peng
    Yu-huan Li
    Dong Li
    Yan-ping Li
    Shuai Meng
    Lin-yan Gao
    Jian-dong Jiang
    Zhuo-rong Li
    The Journal of Antibiotics, 2011, 64 : 177 - 182
  • [50] HCV-RNA IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS (PBMC) BUT NOT IN LIVER - EVIDENCE FOR EXTRAHEPATIC HCV REPLICATION IN THE ABSENCE OF HEPATIC REPLICATION
    SALEH, MG
    TIBBS, CJ
    PEREIRA, LMMB
    BOMFORD, AB
    MCFARLANE, IG
    WILLIAMS, R
    HEPATOLOGY, 1993, 18 (04) : A81 - A81
12345